STERIS plc Restructuring and Related Cost, Expected Number of Positions Eliminated
STERIS plc (STE) reported Restructuring and Related Cost, Expected Number of Positions Eliminated of 300 unit for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated · last filed 2026-08-07
- STERIS plc restructuring and related cost, expected number of positions eliminated for the quarter ending 2020-06-30 was 200.00 plan, a 0.00% change year-over-year.
- STERIS plc restructuring and related cost, expected number of positions eliminated for the quarter ending 2019-06-30 was 200.00 plan.
- STERIS plc restructuring and related cost, expected number of positions eliminated for fiscal 2021 was 200.00 plan.
- STERIS plc restructuring and related cost, expected number of positions eliminated for fiscal 2019 was 200.00 plan.
plan
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 3 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 12 month |
|---|---|---|---|---|
| 2021-03-31 | 200.00 plan 10-K · filed 2021-05-28 | |||
| 2020-12-31 | 200.00 plan 10-Q · filed 2021-02-09 | |||
| 2020-09-30 | 200.00 plan 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 200.00 plan 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | 200.00 plan 8-K · filed 2021-02-09 | |||
| 2019-12-31 | 200.00 plan 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | 200.00 plan 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 200.00 plan 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | 200.00 plan 10-K · filed 2019-05-30 |
unit
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 3 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 12 month |
|---|---|---|---|---|
| 2026-06-30 | 300.00 unit 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 300.00 unit 10-K · filed 2026-05-29 | |||
| 2025-12-31 | 300.00 unit 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | 300.00 unit 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 300.00 unit 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 300.00 unit 10-K · filed 2025-05-29 | |||
| 2024-12-31 | 300.00 unit 10-Q · filed 2025-02-07 | |||
| 2024-09-30 | 300.00 unit 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 300.00 unit 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 300.00 unit 10-K · filed 2024-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |